Amyloidosis Clinical Trials

Scottsdale : Mayo Clinic Arizona Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Glendale : Raffi Minasian MD a Medical Corporation

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Los Angeles : Cedars-Sinai Medical Center

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Los Angeles : Cedars-Sinai Medical Center Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Orange : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Palo Alto : Stanford University Cancer Center

Phase I, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

View More »

San Francisco : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Stanford : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Aurora : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Weston : The Cleveland Clinic Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Elgin : Sherman Health

ECOG E4A08: A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan, and Dexamethasone (BMDex) for Untreated Patients with Systemic Light-chain (AL) Amyloidosis Ineligible for Autologous Stem-cell Transplantation

View More »

Chicago : University of Chicago Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Chicago : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Oak Lawn : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Indianapolis : Indiana University

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Indianapolis : IU Simon Cancer Center Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Baltimore : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Bethesda : National Institute of Arthritis and Musculoskeletal and Skin Diseases

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Boston : Boston Medical Center

A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis

Boston : Boston Medical Center

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Boston : Boston Medical Center

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Boston : Tufts Medical Center

Phase I, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Boston : Tufts Medical Center Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

View More »

Boston : Boston Medical Center HEM/ONCO Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Boston : Boston Medical Center

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Boston : Tufts Medical Center

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Boston : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Ann Arbor : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Detroit : Barbara Ann Karmanos Cancer Institute Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Detroit : Karmanos Cancer Institute

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Rochester : Mayo Clinic

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Rochester : Mayo Clinic

Phase I, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Rochester : Mayo Clinic Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Rochester : Mayo Clinic

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis

New York : Columbia University

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

New York : Memorial Sloan-Kettering Cancer Center

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

New York : Mount Sinai School of Medicine

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

New York : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Cleveland : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Columbus : Ohio State University Medical Center

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Columbus : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Portland : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Philadelphia : Abramson Cancer Center of Univ of Pennsylvania Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Philadelphia : Fox Chase Cancer Center

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Philadelphia : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Pittsburgh : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Nashville : Vanderbilt University Medical Center Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Nashville : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Milwaukee : Froedtert & Medical College of Wisconsin Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Ciudad de Buenos Aires : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Camperdown, NSW : Royal Prince Alfred Hospital Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Nedlands : Sir Charles Gairdner Hospital Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Westmead, NSW : Westmead Hospital Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Woolloongabba : Princess Alexandra Hospital Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Leuven : UZ Leuven

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Leuven : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Curitiba, Parana : Associação Paranaense De Cultura - APC / Hospital Universitário Cajuru da PUCPR

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Ilha do Fundao : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Sofia : University Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski"

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Sofia : University Multiprofile Hospital for Active Treatment "Aleksandrovska"

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Calgary : Tom Baker Cancer Centre Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Toronto : Princess Margaret Hospital Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Toronto : University Health Network, Princess Margaret Hospital

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Vancouver : Vancouver General Hospital Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Santiago : Centro de Estudios Reumatológicos

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Nicosia : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Praha 2 : Vseobecna fakultni nemocnice v Praze

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Arhus N : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Cairo : Al Hussain University Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Cairo : Ain Shams University Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Cairo : Sayed Galal University Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Helsinki : Helsingin yliopistollinen keskussairaala / Meilahti

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Creil : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Creteil : Hôpital Henri Mondor

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Le Kremlin-bicetre : Clinical Trial Site

Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis

Lille : Hôpital Claude Huriez

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Lille : Hopital Huriez, CHRU Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

View More »

Limoges : CHU Limoges Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Limoges : CHU Limoges

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Marseille Cedex : Clinical Trial Site

Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis

Paris : Hospital Saint Louis Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Aachen : Universitätsklinikum der RWTH Aachen

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Altenburg : Klinikum Altenburger Land GmbH, Klinik für Neurologie

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Bad Tölz : Fachklinik für Physikalisch Medizin und Medizinische Rehabilitation, Buchberg-Klinik

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Beelitz : Kliniken Beelitz GmbH, Neurologische Reha-Kliniken

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Berlin : Vivantes Netzwerk, Auguste Viktoria Klinikum, Klinik für Neurologie

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

View More »

Berlin : Charité Universitätsmedizin Berlin Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Boizenburg : MVZ Dreiländereck

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Heidelberg : Universität Heidelberg

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Heidelberg : University Hospital, Amyloidosis Center Med. Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Heidelberg : University of Heidelberg

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Heidelberg : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Mainz : DRK-Schmerz-Zentrum Mainz

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Mühlhausen : Hainich Klinikum Mühlhausen

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Munster : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Munster : Clinical Trial Site

Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis

Perleberg : Kreiskrankenhaus Prignitz, Klinik für Neurologie

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Ribnitz Damgarten : Arztpraxis für Neurologie und Psychiatrie

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Rostock : University of Rostock, Albrecht Kossel Institute

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Teupitz : Asklepios Fachklinik Brandenburg

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Ulm : Arztpraxis für Neurologie Neue Mitte

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy

Athens : General Hospital of Athens Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Patras : University General Hospital of Patras Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Jaipur : Dr. Mukesh Jain Clinic

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Manipal : Kasturba Medical College

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Nadiad : Muljibhai Patel Urological Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

New Delhi : Sir Ganga Ram Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Haifa : Bnei Zion Medical Center

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Holon : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Jerusalem : Hadassah Medical Center - Hadassah University Hosp Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Kfar Saba : Meir Medical Center Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Ramat-Gan : The Chaim Sheba Medical Center

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Bologna : Policlinico S. Orsola-Malpighi Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Bologna : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Messina : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Modena : Azienda Ospedaliero-Universitaria di Modena Policlinico

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Pavia : IRCCS Policlinico San Matteo

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

View More »

Pavia : Centro Amiloidosi Padiglione Forlanini - 3° Piano Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Pavia : Amyloidosis Research & Treatment Center

Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis

Pavia : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Kumamoto : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Matsumoto : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Incheon : Gachon University Gil Medical Center Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Kaunas : Hospital of Lithuanian University of Health Sciences Kaunas Clinics

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Vilnius : Vilnius University Hospital Santariskiu Klinikos

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Aguascalientes : Centenario Hospital Miguel Hidalgo

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Monterrey : Unidad Medica de Tratamientos Avanzados S.C.

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Tlalpan : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Amsterdam : VUMC Ams VUMC Amsterdam Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Groningen : Universitair Medisch Centrum Groningen

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Groningen : Groningen Unit for Amyloidosis Research & Develop. Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Maastricht : Academisch Ziekenhuis Maastricht

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Utrecht : UMC Utrecht Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Lima : Hospital Nacional Arzobispo Loayza

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Olsztyn : Wojewodzki Szpital Specjalistyczny

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Warszawa : ARS RHEUMATICA Sp. z o.o.

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Wroclaw : Akademicki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Lisbon : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Lisbon : Clinical Trial Site

Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis

Porto : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Porto : Clinical Trial Site

Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis

Ekaterinburg : Sverdlovsk Regional Clinical Hospital #1

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Kemerovo : Kemerovo State Medical Academy of Roszdrav

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Moscow : Institute of Rheumatology of RAMN

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Novosibirsk : Research Institute of Clinical and Experimental Lymphology

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

St. Petersburg : North-West State Medical University n.a. I.I. Mechnikov

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Barcelona : Hospital Clinic de Barcelona

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Barcelona : Hospital Clinic I Provincial Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Barcelona : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Barcelona : Clinical Trial Site

Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis

Donostia-San Sebastian : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

View More »

Madrid : Hospital Universitario de la Princesa Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Majorca : Clinical Trial Site

Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis

Malaga : Hospital Civil Carlos Haya

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Palma de Mallorca : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Stockholm : Karolinska Universitetssjukhuset i Huddinge

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Umea : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Umeå : Clinical Trial Site

Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis

Taipei : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Taipei City : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Monastir : Fattouma Bourguiba University Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Sfax : Hedi Chaker University Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Sousse : Sahloul Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Tunis : Hôpital Charles Nicolle

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Tunis : La Rabta Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Adana : Cukurova University Medical Faculty Balcali Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Ankara : Hacettepe University Medical Faculty

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Eskisehir : Eskisehir Osmangazi University Medical Faculty

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Istanbul : Pfizer Investigational Site Updated

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Donetsk : Municipal Treatment-Prophylactic Institution Central City Clinical Hospital #1

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Donetsk : Municipal Medical & Preventive Institution Donetsk Regional Clinical Territorial Medical Association

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Kyiv : National Scientific Center "Institute of cardiology n.a. academician M.D Strazhesko"

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Kyiv : State Institution "Institute of Nephrology of AMS of Ukraine"

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Leeds : Clinical Site

A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC in Healthy Volunteers

London : Clinical Site

A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC in Healthy Volunteers

London : Royal Free Hospital

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

London : University College London Medica School Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Oxford : Oxford University Hospitals NHS Trust Updated

Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis